Textual Corrections to Drug Precursor Regulations

Published: Mon 15th Jun 26

The document corrects two textual errors within Regulation 6 of the preceding Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026.

This document serves as an official correction notice for The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026, addressing two specific typographical errors found on page 9 of the original instrument; the first error involves correcting the placement reference in regulation 6(9)(b) from 'in the third place' to 'in the second place', and the second error corrects the misplaced quotation marks in regulation 6(21)(a) concerning the phrase 'the United Kingdom'.

Arguments For

The correction ensures accuracy and proper legal interpretation of the regulations concerning drug precursors.
Rectifying textual errors prevents potential confusion or incorrect application of the law by enforcement agencies and industry stakeholders.

Arguments Against

The necessity of an official correction suggests initial oversights in the drafting or proofreading process of the primary regulations.
Minor corrections, while important for statutory integrity, may cause temporary administrative burdens as compliance documents need updating.

2026 No. 607

RETAINED EU LAW REFORM

DANGEROUS DRUGS

The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026

ISBN 978-0-34-828414-0

CORRECTION

Page 9, regulation 6(9)(b): 'in the third place' should read 'in the second place'; and

Page 9, regulation 6(21)(a): 'for the 'United Kingdom'' should read 'for 'the United Kingdom''.

June 2026

PRINTED AND PUBLISHED IN THE UNITED KINGDOM BY THE STATIONERY OFFICE LIMITED under the authority and superintendence of Saul Nassé, Controller of His Majesty's Stationery Office and King's Printer of Acts of Parliament.

This is an official correction notice pertaining to Statutory Instrument 2026 No. 607, titled The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026.

The instrument falls under the area of Retained EU Law Reform concerning Dangerous Drugs.

The notice specifies two precise textual amendments that must be made to page 9 of the published regulations.

In regulation 6(9)(b), the phrase 'in the third place' must be substituted with 'in the second place'.

Additionally, in regulation 6(21)(a), the incorrect quotation marking around 'the United Kingdom' needs correction.

This statutory instrument correction was issued in June 2026 and printed by the UK's official government publisher under the authority of the King's Printer of Acts of Parliament.

View Source